vs
Side-by-side financial comparison of American Assets Trust, Inc. (AAT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
American Assets Trust, Inc. is the larger business by last-quarter revenue ($110.6M vs $75.5M, roughly 1.5× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 1.8%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -0.1%).
Personal Assets Trust is a large British investment trust. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The chairman is Iain Ferguson CBE.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
AAT vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $110.6M | $75.5M |
| Net Profit | $6.7M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 23.4% | 22.7% |
| Net Margin | 6.1% | — |
| Revenue YoY | 1.8% | 27.7% |
| Net Profit YoY | -16.3% | — |
| EPS (diluted) | $0.08 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $110.6M | — | ||
| Q4 25 | $110.1M | $75.5M | ||
| Q3 25 | $109.6M | $54.5M | ||
| Q2 25 | $107.9M | $52.4M | ||
| Q1 25 | $108.6M | $46.0M | ||
| Q4 24 | $113.5M | $59.1M | ||
| Q3 24 | $122.8M | $80.5M | ||
| Q2 24 | $110.9M | $47.1M |
| Q1 26 | $6.7M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $4.5M | $8.8M | ||
| Q2 25 | $5.5M | $5.9M | ||
| Q1 25 | $42.5M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $16.7M | $20.3M | ||
| Q2 24 | $11.9M | $-4.5M |
| Q1 26 | — | — | ||
| Q4 25 | 59.4% | 69.3% | ||
| Q3 25 | 60.5% | 77.7% | ||
| Q2 25 | 62.6% | 76.5% | ||
| Q1 25 | 62.0% | 77.1% | ||
| Q4 24 | 61.3% | 76.4% | ||
| Q3 24 | 65.5% | 63.9% | ||
| Q2 24 | 63.6% | 77.4% |
| Q1 26 | 23.4% | — | ||
| Q4 25 | 21.1% | 22.7% | ||
| Q3 25 | 22.6% | 17.6% | ||
| Q2 25 | 24.1% | 12.7% | ||
| Q1 25 | 66.3% | 8.7% | ||
| Q4 24 | 26.5% | 22.6% | ||
| Q3 24 | 30.8% | 27.4% | ||
| Q2 24 | 27.8% | -4.6% |
| Q1 26 | 6.1% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 4.1% | 16.2% | ||
| Q2 25 | 5.1% | 11.2% | ||
| Q1 25 | 39.2% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 13.6% | 25.2% | ||
| Q2 24 | 10.7% | -9.6% |
| Q1 26 | $0.08 | — | ||
| Q4 25 | $0.06 | $0.26 | ||
| Q3 25 | $0.07 | $0.17 | ||
| Q2 25 | $0.09 | $0.12 | ||
| Q1 25 | $0.70 | $0.06 | ||
| Q4 24 | $0.14 | $0.40 | ||
| Q3 24 | $0.28 | $0.41 | ||
| Q2 24 | $0.20 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $118.3M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $1.1B | $130.3M |
| Total Assets | $2.9B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $118.3M | — | ||
| Q4 25 | $129.4M | $97.5M | ||
| Q3 25 | $138.7M | $94.4M | ||
| Q2 25 | $143.7M | $96.0M | ||
| Q1 25 | $143.9M | $93.2M | ||
| Q4 24 | $425.7M | $101.0M | ||
| Q3 24 | $533.0M | $96.7M | ||
| Q2 24 | $114.9M | $96.8M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $2.0B | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.2B | $130.3M | ||
| Q3 25 | $1.2B | $115.3M | ||
| Q2 25 | $1.2B | $104.7M | ||
| Q1 25 | $1.2B | $97.1M | ||
| Q4 24 | $1.2B | $92.1M | ||
| Q3 24 | $1.2B | $71.1M | ||
| Q2 24 | $1.2B | $48.5M |
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.9B | $216.3M | ||
| Q3 25 | $2.9B | $202.9M | ||
| Q2 25 | $3.0B | $194.9M | ||
| Q1 25 | $3.0B | $196.2M | ||
| Q4 24 | $3.3B | $213.3M | ||
| Q3 24 | $3.4B | $220.7M | ||
| Q2 24 | $3.0B | $205.0M |
| Q1 26 | — | — | ||
| Q4 25 | 1.48× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 1.72× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | 14.5% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $167.1M | $14.4M | ||
| Q3 25 | $40.5M | $9.7M | ||
| Q2 25 | $49.2M | $14.1M | ||
| Q1 25 | $36.9M | $3.6M | ||
| Q4 24 | $207.1M | $15.6M | ||
| Q3 24 | $52.4M | $11.0M | ||
| Q2 24 | $59.3M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | $94.9M | $14.4M | ||
| Q3 25 | $23.1M | $9.7M | ||
| Q2 25 | $28.4M | $14.1M | ||
| Q1 25 | $20.4M | $3.6M | ||
| Q4 24 | $136.9M | $15.6M | ||
| Q3 24 | $28.0M | $11.0M | ||
| Q2 24 | $43.6M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | 86.2% | 19.1% | ||
| Q3 25 | 21.1% | 17.7% | ||
| Q2 25 | 26.3% | 26.8% | ||
| Q1 25 | 18.8% | 7.7% | ||
| Q4 24 | 120.7% | 26.4% | ||
| Q3 24 | 22.8% | 13.7% | ||
| Q2 24 | 39.3% | 2.1% |
| Q1 26 | 14.5% | — | ||
| Q4 25 | 65.6% | 0.0% | ||
| Q3 25 | 15.9% | 0.0% | ||
| Q2 25 | 19.3% | 0.0% | ||
| Q1 25 | 15.1% | 0.1% | ||
| Q4 24 | 61.9% | 0.0% | ||
| Q3 24 | 19.9% | 0.0% | ||
| Q2 24 | 14.1% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 8.98× | 1.10× | ||
| Q2 25 | 9.01× | 2.41× | ||
| Q1 25 | 0.87× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.15× | 0.54× | ||
| Q2 24 | 4.98× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAT
| Rental income | $104.4M | 94% |
| Other | $6.2M | 6% |
PBYI
Segment breakdown not available.
